These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6375404)

  • 21. Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya.
    Nguyen-Dinh P; Spencer HC; Chemangey-Masaba S; Churchill FC
    Lancet; 1982 Apr; 1(8276):823-5. PubMed ID: 6122056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy.
    Wang P; Brobey RK; Horii T; Sims PF; Hyde JE
    Mol Microbiol; 1999 Jun; 32(6):1254-62. PubMed ID: 10383765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors.
    Sixsmith DG; Watkins WM; Chulay JD; Spencer HC
    Am J Trop Med Hyg; 1984 Sep; 33(5):772-6. PubMed ID: 6385738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K
    Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa.
    Timmermanns PM; Hess U; Jones ME
    Lancet; 1982 May; 1(8282):1181. PubMed ID: 6122952
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.
    Nguyen-Dinh P; Zevallos-Ipenza A; Magloire R
    Bull World Health Organ; 1984; 62(4):623-6. PubMed ID: 6386210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrimethamine/sulfadoxine resistant falciparum malaria acquired at Dar es Salaam, Tanzania.
    Stahel E; Degrémont A; Lagler U
    Lancet; 1982 May; 1(8281):1118-9. PubMed ID: 6122905
    [No Abstract]   [Full Text] [Related]  

  • 28. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
    Tan-Ariya P; Brockelman CR; Menabandhu C
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polyresistance of asiatic P. falciparum to chloroquine and pyrimethamine-sulfadoxine combination. Apropos of a new case].
    Pays JF; Hugues FC
    Bull Soc Pathol Exot Filiales; 1981; 74(4):406-13. PubMed ID: 7028296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first report of Plasmodium falciparum resistant to chloroquine plus sulphadoxine/pyrimethamine in Rwanda.
    Giboda M; Vanista J; Dastych P
    Trans R Soc Trop Med Hyg; 1988; 82(3):383. PubMed ID: 3068850
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
    Djaman JA; Mazabraud A; Basco L
    Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.
    Abdul-Ghani R; Farag HF; Allam AF
    Acta Trop; 2013 Feb; 125(2):163-90. PubMed ID: 23131424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Falciparum malaria resistant to Fansidar (sulphadoxine-pyrimethamine) occurring in three children of the same family.
    Ponnampalam JT
    Singapore Med J; 1982 Feb; 23(1):37-8. PubMed ID: 7051329
    [No Abstract]   [Full Text] [Related]  

  • 36. Fansidar-resistant falciparum malaria in Papua New Guinea.
    Nurse GT
    Lancet; 1981 Jan; 1(8210):36-7. PubMed ID: 6109064
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the sensitivity of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in vitro].
    Han XL; Liu DQ; Feng XP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):8-10. PubMed ID: 12567461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmodium falciparum RI resistance to quinine and sulphadoxine-pyrimethamine in the Solomon Islands.
    Isaacs RD; Ellis-Pegler RB
    Med J Aust; 1987 Apr; 146(8):449-50. PubMed ID: 3302637
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-resistant malaria.
    Lancet; 1981 Nov; 2(8255):1087-8. PubMed ID: 6118530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.